SMARCA4 and neoplasm: It was also discovered that tumor-suppressor and oncogenic mutant BAF complexes have different effects on PRC eviction [83] and disease-associated mutations in Smarca4 (or BRG1, the ATPase of the BAF complex) disrupt the eviction of PRC1 [85].